InvestorsHub Logo
Followers 52
Posts 5322
Boards Moderated 0
Alias Born 09/16/2013

Re: Pennymoney19 post# 1903

Thursday, 06/04/2020 3:28:54 PM

Thursday, June 04, 2020 3:28:54 PM

Post# of 2794
https://finance.yahoo.com/news/benzingas-top-upgrades-downgrades-june-134201887.html

H.C. Wainwright initiated coverage on Actinium Pharmaceuticals Inc (AMEX: ATNM) with a Buy rating. The price target for Actinium Pharmaceuticals is set at $3.00. For the fourth quarter, Actinium Pharmaceuticals had an EPS of ($0.03), compared to year-ago quarter EPS of ($0.05). The stock has a 52-week-high of $0.41 and a 52-week-low of $0.16. Actinium Pharmaceuticals's stock last closed at $0.22 per share.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ATNM News